Ranolazine and other antianginal therapies in the era of the drug-eluting stent.
Berger
Peter
P
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use; D000787:Angina Pectoris / Q000188:drug therapy*; D002121:Calcium Channel Blockers / Q000627:therapeutic use; D002317:Cardiovascular Agents / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006801:Humans; D009204:Myocardial Revascularization; D010879:Piperazines / Q000627:therapeutic use*; D000069458:Ranolazine; D012306:Risk
D000083:Acetanilides; D000319:Adrenergic beta-Antagonists; D002121:Calcium Channel Blockers; D002317:Cardiovascular Agents; D010879:Piperazines; D000069458:Ranolazine